Updated questionsto be asked at AGM by someone attendingI have organize and modified some that are duplicates.
NMIBC Trial progress
- How concrete are the recently referenced plans to expand the number of sites recruiting for the NMIBC study? For example, have the sites been determined? Have research applications been made? Have local PI's been identified.
- What is your timeline for BTD data submission? Has it happened yet or is it waiting on some threshold that was determined by more recent conversations with the FDA?
- Do they have direction from FDA that they can share as to how many evaluable patients and % CR at what time points that they would need for AA application?
IV formulation for NSCLC and GBM
- What progress has been made towards an IND application? Is one expected this year, next year or beyond that?
Finances
- I would also like some input from our CFO on the short- and long-term plans with respect to funding. Is the company going to rely only on PPs?
Other
- What is within your definition of commercialization, and do you expect it this year?
- What is the status of vaccine trials? Any timeline?
- Does the HCA know you exist? (I don’t know what this means – Dawg)
- Has the company sought any financial assistance from Health Canada to pursue the Vaccine research?
- What is the status with the collaboration with LI-ka shing knowledge institute. Is the management planning to seek any financial participation from them or is it purely a contract to share the research facilities that are available with St. Mike's